by Jakub Wolski | Apr 7, 2022 | Blog
The conflict in Eastern Europe caused an uninterrupted influx of Ukrainian immigrants to Poland. Some of them started their participation in clinical trials before the war began. The focus of the medical community is now on the interests and well-being of these...
by Jakub Wolski | Mar 28, 2022 | Blog
The European Medicines Regulatory Network has adopted a Common Standard for the electronic product information (ePI) on medicines in the European Union (EU). The product information (PI) of a medicine includes the package leaflet for patients and the summary of...
by Jakub Wolski | Sep 23, 2021 | Blog
Even though names such as cystic fibrosis, Huntington’s disease, hemophilia, retinoblastoma or amyotrophic lateral sclerosis often come up in medical shows, in real life they fall in the category of rare diseases. In the European Union, a disease is defined as...
by Jakub Wolski | Sep 22, 2021 | Blog
Are you… registering the company abroad? placing new products on the market? struggling to reach another milestone in your clinical study? If you want to successfully grow your business or conduct comprehensive research, do not limit yourself to your home market....
by Jakub Wolski | Aug 6, 2021 | Blog
Before a new medical device is placed on the market and authorized for use, it must undergo a conformity assessment procedure. Its aim is to verify whether the product meets all the applicable core requirements. Labelling and instructions for use are among the...
by Jakub Wolski | Aug 2, 2021 | Blog
Provide better customer’s experience by communicating with your target groups in their own language As medical development requires the introduction of new solutions to a wider market, there is a growing awareness of the need to use appropriate communication in order...
